Personal tools

UBERON:0000479

From FANTOM5_SSTAR

Jump to: navigation, search

Name:tissue
Namespace:FANTOM
Definition:"Anatomical structure, that consists of similar cells and intercellular matrix, aggregated according to genetically determined spatial relationships." [CARO:0000043, CARO:MAH, FMA:9637]
Xrefs:
links:

AAO:0000607
AAO:0010054
AEO:0000043
BILA:0000043
CARO:0000043
EHDAA2:0003043
FBbt:00007003
FMA:9637
galen:Tissue
HAO:0000043
MA:0003002
MESH:A.10
ncithesaurus:Tissue
NIF_GrossAnatomy:birnlex_19
TAO:0001477
TGMA:0001844
WBbt:0005729
XAO:0003040

ZFA:0001477
Synonyms: "portion of tissue" EXACT [CARO:0000043]
"simple tissue" EXACT [AEO:0000043]
"tissue portion" EXACT []
Comments:This class was sourced from CARO, which was initially sourced from FMA. Nomenclature changes have been made. Note also AEO introduces a class AEO:0000013 'single-cell tissue'
Alt_id: UBERON:CARO_0000043-FBbt_00007003-XAO_0003040-ZFA_0001477
Subset: upper_level

Ontology association
Each term has an is_a parent in the Uberon Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to UBERON ontologies.

link to ontology dataset
data


Parents

is_a:UBERON:0010000(multicellular anatomical structure)
part_of:UBERON:0000468(multi-cellular organism)



Children

is a:UBERON:0000119 (cell layer),UBERON:0000412 (dermal papilla),UBERON:0001744 (lymphoid tissue),UBERON:0001758 (periodontium),UBERON:0002384 (connective tissue),UBERON:0002385 (muscle tissue),UBERON:0003091 (thyroid primordium),UBERON:0003104 (mesenchyme),UBERON:0003714 (neural tissue),UBERON:0004128 (optic vesicle),UBERON:0005291 (embryonic tissue),UBERON:0005292 (extraembryonic tissue),UBERON:0005388 (photoreceptor array),UBERON:0005426 (lens vesicle),UBERON:0005427 (corneal primordium),UBERON:0005497 (non-neural ectoderm),UBERON:0005932 (bulb of hair follicle),UBERON:0005933 (hair root sheath),UBERON:0005969 (reticulum trabeculare),UBERON:0007475 (matrix-based tissue),UBERON:0010536 (nephron progenitor),UBERON:0012429 (hemopoietic tissue),FF:10008-101B6 (Universal RNA - Mouse Normal Tissues Biochain, pool1)
derives from:FF:0000004 (tissue sample),FF:0000317 (mouse pregnant tissue sample),FF:0000998 (adult tissue sample),FF:0000999 (fetal tissue sample)
part of:FF:0000004 (tissue sample),FF:0000317 (mouse pregnant tissue sample),CL:0000864 (tissue-resident macrophage),FF:0000998 (adult tissue sample),FF:0000999 (fetal tissue sample)

Ontology Tree: Loaded from BioPortal


FF samples
It includes FANTOM5 samples that overlay the Uberon ontology


Human (Homo sapiens)

  • 10000-101A1 (Clontech Human Universal Reference Total RNA, pool1)
  • 10001-101A3 (Clontech Mouse Universal Reference Total RNA, pool1)
  • 10002-101A5 (SABiosciences XpressRef Human Universal Total RNA, pool1)
  • 10003-101A7 (SABiosciences XpressRef Mouse Universal Total RNA, pool1)
  • 10004-101A9 (chicken embryo whole body, day10 (HH37))
  • 10006-101B2 (Universal RNA - Dog Normal Tissues Biochain, pool1)
  • 10007-101B4 (Universal RNA - Human Normal Tissues Biochain, pool1)
  • 10008-101B6 (Universal RNA - Mouse Normal Tissues Biochain, pool1)
  • 10009-101B8 (Universal RNA - Rat Normal Tissues Biochain, pool1)
  • 10010-101C1 (adipose tissue, adult, pool1)

... further results Mouse (Mus musculus)

  • 10000-101A1 (Clontech Human Universal Reference Total RNA, pool1)
  • 10001-101A3 (Clontech Mouse Universal Reference Total RNA, pool1)
  • 10002-101A5 (SABiosciences XpressRef Human Universal Total RNA, pool1)
  • 10003-101A7 (SABiosciences XpressRef Mouse Universal Total RNA, pool1)
  • 10004-101A9 (chicken embryo whole body, day10 (HH37))
  • 10006-101B2 (Universal RNA - Dog Normal Tissues Biochain, pool1)
  • 10007-101B4 (Universal RNA - Human Normal Tissues Biochain, pool1)
  • 10008-101B6 (Universal RNA - Mouse Normal Tissues Biochain, pool1)
  • 10009-101B8 (Universal RNA - Rat Normal Tissues Biochain, pool1)
  • 10010-101C1 (adipose tissue, adult, pool1)

... further results


Enrichment analysis: top 100 FFCP enriched with this ontology term TOP 100 FANTOM5 Cage Peaks enriched with UBERON:0000479 (tissue), sorted by p-values
Analyst: Hideya Kawaji

link to source dataset
human : data
mouse : data


P-valueFFCPShort description
7.1e-18FFCP PHASE2:Hg19::chr2:145275162..145275202,-#_d87e74116553e4db084dd036854a3addp2@ZEB2
7.1e-18FFCP PHASE1:Hg19::chr2:145275162..145275202,-#_d87e74116553e4db084dd036854a3addp2@ZEB2
8.1e-17FFCP PHASE2:Hg19::chr12:66582919..66583077,+#_6c49b757455984cc549b3377120bf86cp1@IRAK3
8.1e-17FFCP PHASE1:Hg19::chr12:66582919..66583077,+#_6c49b757455984cc549b3377120bf86cp1@IRAK3
2.1e-16FFCP PHASE1:Hg19::chr9:125133293..125133309,+#_27ff11ad81116853db1ba1406b70d0adp2@PTGS1
2.1e-16FFCP PHASE2:Hg19::chr9:125133293..125133309,+#_27ff11ad81116853db1ba1406b70d0adp2@PTGS1
6.19e-16FFCP PHASE2:Hg19::chr5:88179017..88179046,-#_1fd6ea83bbbb20cd763a5f389fe344acp2@MEF2C
6.19e-16FFCP PHASE1:Hg19::chr5:88179017..88179046,-#_1fd6ea83bbbb20cd763a5f389fe344acp2@MEF2C
6.4e-16FFCP PHASE1:Hg19::chrX:11445856..11445943,-#_f50d0f3e9c0160287c2f7622e09e23d1p1@ARHGAP6
6.4e-16FFCP PHASE2:Hg19::chrX:11445856..11445943,-#_f50d0f3e9c0160287c2f7622e09e23d1p1@ARHGAP6
7.77e-16FFCP PHASE1:Hg19::chr20:23618584..23618603,-#_8254c2f83c6d3a84bbaf56087160fb0fp1@CST3
7.77e-16FFCP PHASE2:Hg19::chr20:23618584..23618603,-#_8254c2f83c6d3a84bbaf56087160fb0fp1@CST3
1.26e-15FFCP PHASE1:Hg19::chr6:119670919..119670943,-#_a41b922a6a38c233d952fb856afe11bdp1@MAN1A1
1.26e-15FFCP PHASE2:Hg19::chr6:119670919..119670943,-#_a41b922a6a38c233d952fb856afe11bdp1@MAN1A1
1.42e-15FFCP PHASE2:Hg19::chr12:51318790..51318817,+#_9126cd7c100e607a02adaa433e0fac96p1@METTL7A
1.42e-15FFCP PHASE1:Hg19::chr12:51318790..51318817,+#_9126cd7c100e607a02adaa433e0fac96p1@METTL7A
1.54e-15FFCP PHASE1:Hg19::chr10:45455207..45455263,+#_26c214f47dad4ecad3b083bfcee859b5p1@RASSF4
1.54e-15FFCP PHASE2:Hg19::chr10:45455207..45455263,+#_26c214f47dad4ecad3b083bfcee859b5p1@RASSF4
3.24e-15FFCP PHASE2:Hg19::chr4:8430152..8430200,-#_ed2f8fa4e7e60659e39be5ed10883153p1@ACOX3
3.24e-15FFCP PHASE1:Hg19::chr4:8430152..8430200,-#_ed2f8fa4e7e60659e39be5ed10883153p1@ACOX3
4.56e-15FFCP PHASE1:Hg19::chr5:114938090..114938226,-#_3287a75c4e846d77123707d26f82f3dcp1@TICAM2, p2@TMED7-TICAM2
4.56e-15FFCP PHASE2:Hg19::chr5:114938090..114938226,-#_3287a75c4e846d77123707d26f82f3dcp1@TICAM2, p2@TMED7-TICAM2
5.12e-15FFCP PHASE1:Hg19::chr2:230135937..230136016,-#_90ef144b7a2843b63a7748bf97b61ef9p1@PID1
5.12e-15FFCP PHASE2:Hg19::chr2:230135937..230136016,-#_90ef144b7a2843b63a7748bf97b61ef9p1@PID1
6.83e-15FFCP PHASE1:Hg19::chr4:159093517..159093533,-#_1acafb70c8eb74d76cd10ed82bf6c8cdp1@FAM198B
6.83e-15FFCP PHASE2:Hg19::chr4:159093517..159093533,-#_1acafb70c8eb74d76cd10ed82bf6c8cdp1@FAM198B
7.62e-15FFCP PHASE2:Hg19::chr5:88178983..88179012,-#_7ab6bc653185eb1b5324af7783bc7b69p1@MEF2C
7.62e-15FFCP PHASE1:Hg19::chr5:88178983..88179012,-#_7ab6bc653185eb1b5324af7783bc7b69p1@MEF2C
9.58e-15FFCP PHASE1:Hg19::chr9:113800705..113800781,-#_73832b96a8625c8d7bd7bb2444588f9ap1@LPAR1
9.58e-15FFCP PHASE2:Hg19::chr9:113800705..113800781,-#_73832b96a8625c8d7bd7bb2444588f9ap1@LPAR1
1.01e-14FFCP PHASE1:Hg19::chr4:185747114..185747128,-#_e7412fd89c68a25dd77fd9e481f7ee5ep1@ACSL1
1.01e-14FFCP PHASE2:Hg19::chr4:185747114..185747128,-#_e7412fd89c68a25dd77fd9e481f7ee5ep1@ACSL1
1.2e-14FFCP PHASE2:Hg19::chr19:36246113..36246265,+#_6f58953efbecd4a67d95c3863ac62a33p@chr19:36246113..36246265, +
1.2e-14FFCP PHASE1:Hg19::chr19:36246113..36246265,+#_6f58953efbecd4a67d95c3863ac62a33p@chr19:36246113..36246265, +
1.53e-14FFCP PHASE2:Hg19::chr11:27015649..27015680,+#_dc4b6d72ff2799ef550cbe6a56d2c3c4p1@FIBIN
1.53e-14FFCP PHASE1:Hg19::chr11:27015649..27015680,+#_dc4b6d72ff2799ef550cbe6a56d2c3c4p1@FIBIN
1.86e-14FFCP PHASE2:Hg19::chr2:145277640..145277771,-#_b08dc61f63193979848817a6debf4bbcp1@ZEB2
1.86e-14FFCP PHASE1:Hg19::chr2:145277640..145277771,-#_b08dc61f63193979848817a6debf4bbcp1@ZEB2
2.53e-14FFCP PHASE1:Hg19::chr17:8055699..8055729,-#_7ecf834e6977e1cff21d5e992bbbae10p2@PER1
2.53e-14FFCP PHASE2:Hg19::chr17:8055699..8055729,-#_7ecf834e6977e1cff21d5e992bbbae10p2@PER1
2.91e-14FFCP PHASE1:Hg19::chr15:74726283..74726306,-#_38753951f169bbc0b41ee098f5a802e9p1@SEMA7A
2.91e-14FFCP PHASE2:Hg19::chr15:74726283..74726306,-#_38753951f169bbc0b41ee098f5a802e9p1@SEMA7A
3.33e-14FFCP PHASE2:Hg19::chr3:142838629..142838697,+#_e34951ac9ceea5486177b4ba6cf6a106p1@CHST2
3.33e-14FFCP PHASE1:Hg19::chr3:142838629..142838697,+#_e34951ac9ceea5486177b4ba6cf6a106p1@CHST2
3.48e-14FFCP PHASE2:Hg19::chr18:5544022..5544045,-#_a288476f247dbdd47b2b8def1919f423p4@EPB41L3
3.48e-14FFCP PHASE1:Hg19::chr18:5544022..5544045,-#_a288476f247dbdd47b2b8def1919f423p4@EPB41L3
4.18e-14FFCP PHASE1:Hg19::chr1:32169580..32169599,-#_8606b7c9ea912875b775809857cce658p2@COL16A1
4.18e-14FFCP PHASE2:Hg19::chr1:32169580..32169599,-#_8606b7c9ea912875b775809857cce658p2@COL16A1
4.65e-14FFCP PHASE2:Hg19::chr1:209848749..209848764,+#_c360509826620bf4994df60729e9e9e1p1@G0S2
4.65e-14FFCP PHASE1:Hg19::chr1:209848749..209848764,+#_c360509826620bf4994df60729e9e9e1p1@G0S2
5.64e-14FFCP PHASE1:Hg19::chr13:77460532..77460548,-#_9913e6fce5aa05e1db4ac51d1c7d5ab3p1@KCTD12
5.64e-14FFCP PHASE2:Hg19::chr13:77460532..77460548,-#_9913e6fce5aa05e1db4ac51d1c7d5ab3p1@KCTD12
6.18e-14FFCP PHASE2:Hg19::chr19:36246086..36246335,-#_8cd197e0a892a5b41114ef4b409c344fp2@HSPB6
6.18e-14FFCP PHASE1:Hg19::chr19:36246086..36246335,-#_8cd197e0a892a5b41114ef4b409c344fp2@HSPB6
6.35e-14FFCP PHASE2:Hg19::chr8:48650715..48650735,-#_28e9ef2d2e30c75b6cf699a02dc479fbp1@CEBPD
6.35e-14FFCP PHASE1:Hg19::chr8:48650715..48650735,-#_28e9ef2d2e30c75b6cf699a02dc479fbp1@CEBPD
6.95e-14FFCP PHASE1:Hg19::chr7:120628737..120628818,+#_50225ab568aec74485620f8966586648p1@C7orf58
6.95e-14FFCP PHASE2:Hg19::chr7:120628737..120628818,+#_50225ab568aec74485620f8966586648p1@C7orf58
7.19e-14FFCP PHASE2:Hg19::chr4:185747194..185747242,-#_c72a46549e4adbb209699164c515aa5cp2@ACSL1
7.19e-14FFCP PHASE1:Hg19::chr4:185747194..185747242,-#_c72a46549e4adbb209699164c515aa5cp2@ACSL1
7.42e-14FFCP PHASE2:Hg19::chr17:66951474..66951550,-#_527db091d0e87994e3d4b9a393c983e4p1@ABCA8
7.42e-14FFCP PHASE1:Hg19::chr17:66951474..66951550,-#_527db091d0e87994e3d4b9a393c983e4p1@ABCA8
7.61e-14FFCP PHASE1:Hg19::chr12:91576561..91576613,-#_3870fdddfbac4db3b354cd74c67d8a73p1@DCN
7.61e-14FFCP PHASE2:Hg19::chr12:91576561..91576613,-#_3870fdddfbac4db3b354cd74c67d8a73p1@DCN
8.37e-14FFCP PHASE2:Hg19::chr18:5543988..5544019,-#_0ef80e070280302b8117312c2494ba50p1@EPB41L3
8.37e-14FFCP PHASE1:Hg19::chr18:5543988..5544019,-#_0ef80e070280302b8117312c2494ba50p1@EPB41L3
1.12e-13FFCP PHASE1:Hg19::chr9:113800467..113800520,-#_90108eb7b804ffee73d6fe85ffda7bb8p2@LPAR1
1.12e-13FFCP PHASE2:Hg19::chr9:113800467..113800520,-#_90108eb7b804ffee73d6fe85ffda7bb8p2@LPAR1
1.23e-13FFCP PHASE1:Hg19::chr6:119670450..119670481,-#_70eec7cbe71eb3cc8e39deeb45a1f9cep1@X74837
1.23e-13FFCP PHASE2:Hg19::chr6:119670450..119670481,-#_70eec7cbe71eb3cc8e39deeb45a1f9cep1@X74837
1.8e-13FFCP PHASE2:Hg19::chr2:40679186..40679297,-#_33c8bd92691b096faf8818c24789ac63p1@SLC8A1
1.8e-13FFCP PHASE1:Hg19::chr2:40679186..40679297,-#_33c8bd92691b096faf8818c24789ac63p1@SLC8A1
2.22e-13FFCP PHASE2:Hg19::chr5:78281092..78281154,-#_be8af8681971bfcb5c3460fa87c1da59p1@ARSB
2.22e-13FFCP PHASE1:Hg19::chr5:78281092..78281154,-#_be8af8681971bfcb5c3460fa87c1da59p1@ARSB
2.69e-13FFCP PHASE1:Hg19::chr9:125133315..125133339,+#_24b2bc406606faedb95e4a1419374931p1@PTGS1
2.69e-13FFCP PHASE2:Hg19::chr9:125133315..125133339,+#_24b2bc406606faedb95e4a1419374931p1@PTGS1
2.77e-13FFCP PHASE2:Hg19::chr19:36247921..36247937,-#_063f90a655aa35473db4ad0d08c2eaefp1@HSPB6
2.77e-13FFCP PHASE1:Hg19::chr19:36247921..36247937,-#_063f90a655aa35473db4ad0d08c2eaefp1@HSPB6
2.88e-13FFCP PHASE2:Hg19::chr18:77711625..77711675,-#_bfce42e1cfacecc47bdd9ef24b2b42c1p1@PQLC1
2.88e-13FFCP PHASE1:Hg19::chr18:77711625..77711675,-#_bfce42e1cfacecc47bdd9ef24b2b42c1p1@PQLC1
2.91e-13FFCP PHASE1:Hg19::chr3:187463248..187463264,-#_594004b4c90c4671520adb68f72f7cfep1@BCL6
2.91e-13FFCP PHASE2:Hg19::chr3:187463248..187463264,-#_594004b4c90c4671520adb68f72f7cfep1@BCL6
3.18e-13FFCP PHASE1:Hg19::chr2:160654706..160654744,-#_af4521461de2737c3ade81c5d68c859ep1@CD302
3.18e-13FFCP PHASE2:Hg19::chr2:160654706..160654744,-#_af4521461de2737c3ade81c5d68c859ep1@CD302
3.87e-13FFCP PHASE1:Hg19::chr10:33623460..33623478,-#_49032a210bdc3675780b32e0bc1e1172p3@NRP1
3.87e-13FFCP PHASE2:Hg19::chr10:33623460..33623478,-#_49032a210bdc3675780b32e0bc1e1172p3@NRP1
5.08e-13FFCP PHASE1:Hg19::chr6:35310395..35310410,+#_cd0e8d17aac1b2b911bd1b4df7c6254dp2@PPARD
5.08e-13FFCP PHASE2:Hg19::chr6:35310395..35310410,+#_cd0e8d17aac1b2b911bd1b4df7c6254dp2@PPARD
5.11e-13FFCP PHASE1:Hg19::chr11:3186494..3186545,-#_c83f88011d939d3d9db97225cac12de2p1@OSBPL5
5.11e-13FFCP PHASE2:Hg19::chr11:3186494..3186545,-#_c83f88011d939d3d9db97225cac12de2p1@OSBPL5
5.41e-13FFCP PHASE1:Hg19::chr15:90358048..90358103,-#_4b13681a9f0c85f9a24ae84420aa4640p1@ANPEP
5.41e-13FFCP PHASE2:Hg19::chr15:90358048..90358103,-#_4b13681a9f0c85f9a24ae84420aa4640p1@ANPEP
5.45e-13FFCP PHASE2:Hg19::chr19:14228521..14228536,-#_49956c9acfffe60360aacaefebff0200p2@PRKACA
5.45e-13FFCP PHASE1:Hg19::chr19:14228521..14228536,-#_49956c9acfffe60360aacaefebff0200p2@PRKACA
5.62e-13FFCP PHASE1:Hg19::chr1:145039949..145039967,-#_e8baccde2d334fb25e97e9cfc1a9fc96p1@PDE4DIP
5.62e-13FFCP PHASE2:Hg19::chr1:145039949..145039967,-#_e8baccde2d334fb25e97e9cfc1a9fc96p1@PDE4DIP
5.69e-13FFCP PHASE2:Hg19::chr11:118478313..118478358,+#_ca90246815652f512ec55e87f8786bd8p1@PHLDB1
5.69e-13FFCP PHASE1:Hg19::chr11:118478313..118478358,+#_ca90246815652f512ec55e87f8786bd8p1@PHLDB1
6.13e-13FFCP PHASE1:Hg19::chr2:145274900..145274934,-#_a3ec8a66b71392b112c8612241f08a37p4@ZEB2
6.13e-13FFCP PHASE2:Hg19::chr2:145274900..145274934,-#_a3ec8a66b71392b112c8612241f08a37p4@ZEB2